Lignin-Derived Pharmaceuticals

Date:21 Jan 2023

Application

• Development of antimicrobial, antiviral, and antitumor drugs from lignin.
• Sustainable pharmaceutical applications using lignin-based materials for drug delivery systems.

Description

This project focuses on the valorization of lignin, a major component of lignocellulosic biomass, which is often underutilized. It explores various extraction methods like organosolv and ionic liquid processes to isolate lignin and its potential for pharmaceutical applications. The project reviews recent advances in developing lignin-derived compounds for antimicrobial, antiviral, and antitumor purposes. Key areas for future research include improving extraction technologies and enhancing the clinical viability of lignin-based therapeutics.

Pathway Description:

The process involves extracting lignin from lignocellulosic biomass using methods like organosolv and ionic liquid techniques. The extracted lignin is then analyzed for its chemical properties and potential pharmaceutical applications. It is used to create value-added products such as antimicrobial, antiviral, and antitumor compounds. Additionally, lignin-derived materials are developed for controlled drug delivery systems.